Madrigal Pharmaceuticals, Inc. (MDGL)
MDGL price $457.30 -10.24 -2.19%
- Ticker
- MDGL
- Price
- $457.30
- Change
- -10.24 -2.19%
- Market cap
- $10.57B
- P/E
- -36.27
- Forward P/E
- 80.50
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 62
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for…